News Sentiment

RARE sentiment intelligence

Ultragenyx news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 50 Balanced news tone 54 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 33.82 Week of 10 Jul 2026
Weighted tone 50/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

82/100 classification confidence.

Company focus 46

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend active

+1.0% over one week, +38.9% over four weeks, trend active, and near fair-value range.

Latest direct headline Negative

Law firm probes Ultragenyx officers for alleged false statements on drug trial results

Market Reaction

Balanced read

59/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 82/100 classification
One-week reaction 1.0% Price digesting
Trend fit Trend active 38.9% over four weeks
Fair value -10.9% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 9
Neutral 36
Negative 9

Relevance

Why the article matched

Direct first
Direct company coverage 46
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
Market source 9
Stock Titan 9
TradingView 5
simplywall.st 5
www.marketscreener.com 4
GlobeNewswire 3
Moomoo 2
Investing.com 2

Event Lens

What the news is about

Classified themes
Market update 32
Earnings 13
Regulatory and legal 3
Analyst action 3
Deals and strategy 1
Macro sensitivity 1
Balance sheet 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-54 of 54